Product Information
RIFAMPIN 300 MG CAPSULE is a generic product labeled by PuraCap Laboratories LLC, priced at $0.6891 per EA under NDC 24658080260. Its NADAC has been published 159 times since Jun 14, 2023.
Strength
300 mg/1
Manufacturer
PuraCap Laboratories LLCNDC
24658080260
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA064150On Market Since
3/14/2023
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 300 MG CAPSULE has been published 159 times since Jun 14, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6891 per EA |
|---|---|
| All-time high | $0.7340 (Apr 16, 2025) |
| All-time low | $0.4888 (Nov 20, 2024) |
| 52-week high | $0.7246 |
| 52-week low | $0.6805 |
| Median price | $0.6910 |
| Average price | $0.6722 |
| Largest weekly change | -26.5% (Nov 20, 2024) |
| Weeks tracked | 159 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIFAMPIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 300 MG CAPSULE, manufactured by PuraCap Laboratories LLC, is $0.6891 per EA (NDC 24658080260), effective Jun 24, 2026.
How has the price of RIFAMPIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 300 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 159 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 300 MG CAPSULE?
Since Jun 14, 2023, the NADAC for RIFAMPIN 300 MG CAPSULE has ranged from a low of $0.4888 (Nov 20, 2024) to a high of $0.7340 (Apr 16, 2025), with a median of $0.6910 per EA.
Are there cheaper alternatives to RIFAMPIN 300 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as RIFAMPIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures RIFAMPIN 300 MG CAPSULE?
RIFAMPIN 300 MG CAPSULE (NDC 24658080260) is labeled by PuraCap Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification